Jasdeep Sharma
Dermatology · Sacramento, CANPI 1386684561
Payments from drug & device makers
Across 51 payments — averaging $104.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$911
- Lilly USA, LLC$678
- Arcutis Biotherapeutics, Inc.$514
- UCB, Inc.$465
- Sun Pharmaceutical Industries Inc.$381
- E.r. Squibb & Sons, L.L.C.$324
- plus $2K from 15 others
What the payments were for
- Food & beverage$5,315100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $911 |
| Lilly USA, LLC | 7 | $678 |
| Arcutis Biotherapeutics, Inc. | 5 | $514 |
| UCB, Inc. | 4 | $465 |
| Sun Pharmaceutical Industries Inc. | 4 | $381 |
| E.r. Squibb & Sons, L.L.C. | 3 | $324 |
| Incyte Corporation | 2 | $245 |
| Janssen Scientific Affairs, LLC | 2 | $225 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $177 |
| Boehringer Ingelheim | 2 | $174 |
| Johnson & Johnson | 1 | $130 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Genentech USA, Inc. | 1 | $125 |
| DUSA Pharmaceuticals, Inc. | 1 | $124 |
| Novartis | 1 | $123 |
| LEO Pharma Inc. | 1 | $123 |
| Botanix SB Inc | 1 | $122 |
| Dermavant Sciences, Inc. | 1 | $110 |
| Pfizer | 1 | $108 |
| Sanofi | 1 | $95 |
| Amgen | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,315 in reported general payments places this provider in the 65th percentile of 1,875 dermatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TremfyaGuselkumab | 12 | $125,596 |
| Dupixent PenDupilumab | 16 | $57,755 |
| Amjevita(Cf) AutoinjectorAdalimumab-Atto | 31 | $49,485 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $37,426 |
| Clobetasol Propionate | 113 | $4,377 |
| Fluorouracil | 62 | $2,539 |
| VecticalCalcitriol | 15 | $2,294 |
| Acitretin | 23 | $2,192 |
| Calcipotriene | 26 | $2,185 |
| Mycophenolate Mofetil | 24 | $2,018 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 35 | $1,822 |
| Triamcinolone Acetonide | 68 | $1,712 |
| Fluocinonide | 50 | $1,667 |
| Betamethasone Valerate | 20 | $1,242 |
| Hydrocortisone | 65 | $1,198 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonTremfya | $130 | $125,59612 claims |
| Ortho Dermatologics, A Division Of Bausch Health US, LLCRetin-A | $177 | $88837 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,875 dermatology providers in California.
Other dermatology in Sacramento
- Raja SivamaniSacramento$11.8M
- Emanual MaverakisSacramento$3.5M
- Jennifer OrnelasSacramento$1.3M
- Emil TanghettiSacramento$1.2M
- Stephanie leSacramento$1.1M
- Vivian LaquerIrvine$20.9M
- Howard SofenLos Angeles$16.1M
- Jennifer SoungSanta Ana$10.3M
- Stacy SmithEncinitas$7.9M
- Paul YamauchiSanta Monica$7.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.